IGI Logo
Toggle Navigation
News
Budget 2024
Hindi
Hindi News
Top News
Screeners
Stocks
Stocks Screener
Stock
News
Stock Market Home Page
Stock News
Industry News
Economy News
Stock on the move
Expert Views
Research Reports
Company Result
Comp Info And Fundamentals
Company Profile
Equity
Financial Ratios
Results
Balance Sheet
Profit And Loss
Cash Flow
Share Holding
Derivatives (F&O)
Get Quotes
Market Watch
Top Gainers
Top Losers
Top Traded Quantity
Top Traded Value
Most Active Puts
Derivatives (F&O)
Most Active Calls
Put Call Ratio
Highest In Premium
Daily Settlement Price
FII and DII Statistics
Open Interest: Highest In OI
Open Interest: Lowest In OI
Derivatives (F&O)
Open Interest: Increase in OI Increase in Price
Open Interest: Decline in OI Decrease in Price
Derivative Watch
Derivatives Dashboard
Historical Data
List of Underlyings & Underlying Info
Derivative Watch
Derivatives Dashboard
Market Reports
Top Gainers
Top Losers
Monthly High/Low
52 Week High
52 Week Low
Market Cap Gainers
Market Cap Losers
PE Ratio
>More Market Reports
IPO
News
IPO News
IPO Issue Reports
Commodity
Commodity Market
Commodity Home Page
Commodity News
Commodity Reports
Market Details
Get Quotes
Top Gainers
Top Losers
Top Volume
Top Value
Top Gainers Spot Market
Top Losers Spot Market
High & Low
Commodity Indices
Technical Analysis
Advance Declines
High & Low
Highest In OI
Lowest OI
Increase In Open Interest(%)
Descrease In Open Interest(%)
Currency
News
Currency News
Economy News
Currency Reports
Mutual Fund
News
Mutual Fund Home Page
Mutual Fund News
Mutual Fund Details
Mutual Fund Home Page
Scheme Profile
Mutual fund Investment
Mutual Fund Share Holding
Mutual Fund Statistics
Mutual fund Gainers
Mutual fund Losers
Biggest Schemes
Best Performers
Latest Dividend Details
Tools
Multi Scheme Comparison Tool
Dividend Details
Performance Map
Mutual fund Investment
Mutual fund Share Holding
Mutual Fund Search Category Rankings
Widgets
Stock Widgets
Watchlist
Heatmap
Mutual Fund Widgets
Watchlist
Wealth
World
Tips
Intraday Tips
Market Outlook
Stock Tips
Commodity Tips
Currency Tips
Reports
Short Term Investment Opportunities
Long Term Investment Opportunities
Sector Analysis
Commodity Reports
Currency Reports
Mutual Fund Analysis
Podcast
Videos
Videos Category
Business Videos
Budget Videos
News And Politics
Entertainment Videos
Sports Videos
Lifestyle And Fashion Videos
Global News Videos
More
Astrology
Women
Politics
Entertainment
Car&Bike
Gadgets
Lifestyle
Sports
Health
Fashion
Diwali Reports
Diwali Expert Reports
News
Stock Market
Diwali Expert Views
Commodities
Budget News
Special Event Expert Views
Expert Views
Broking Firm Views
Company News
Industry News
Economy News
Stock On The Move
Market Outlook
Beyond Market Sports
IPO Reports
IPO More News
Commodities Reports
Currency News
Mutual Fund More News
World Market More News
Astrology
Mutual Fund Analysis
Currency Report
Diwali Report
Mutual Fund Expert Views
Budget Expert Views
Broking Firm Views - Sector Report
Broking Firm Views - Short Term Report
Women
Broking Firm Views - Long Term Report
Top Stories
Top News
IPO Top News
Commodity Top News
Currency Top News
Mutual Fund Top News
World Top News
Special Event Reports
Beyond Market India
Beyond Market Entertainment
Beyond Market Car
Beyond Market Gadgets
Beyond Market Life Style
Beyond Market Health
Beyond Market Fashion
Wealth
IPO Analysis
Expert View Institution
Startup Speak
Diwali Technical Report
Diwali Market Outlook
Podcast - Market Ki Awaaz
Videos Business
Videos Entertainment
Videos Sports
Videos
Videos Lifestyle And Fashion
Videos News And Politics
Videos Global News
Company Result
Budget 2024 Sector Reports
Budget Industry
Budget Wishlist
Startup Expections
Budget Economic Servey
Startup
Budget Bites
Search
Result Synopsis Sun Pharma reported a healthy margin beat on back of lower R&D spend which offset presumed weakness in Taro revenues; additionally, management indicated specialty business grew QoQ except for Levulan. We expect Leqselvi for Alopecia Areata to drive growth over next 12-24 months and beyond looking at the large sized market and revenues of competing brands. Ramp up of Leqselvi and continued growth in Ilumya/Winlevi should drive the specialty sales supported by likely Nidl...
Add Sun Pharma Ltd For Target Rs. 765 By Yes Securities
Specialty/DF drive earnings Leqselvi faces injunction hurdle * Sun Pharma (SUNP) delivered better-than-expected 1QFY25 earnings, led by an improved segmental mix and lower RM costs. Lower-than-expected R&D spending led to margin improvement in 1Q. The performance was affected partly by a muted show in ROW sales. * We raise our earnings estimates by 2% each in FY25/FY26, factoring in a) superior execution in domestic formulation (DF) segment, b) reduced R&D spending, and c) a ...
Buy Sun Pharma Ltd For Target Rs. 1,980 By Motilal Oswal Financial Services
Sun Pharma (SUNP) 1QFY25 result was a miss on revenue while EBITDA/PAT beat our estimates. Overall revenues grew 6% YoY to Rs125bn (our est. Rs130bn), led by India/EM delivering 16%/11% YoY growth offset by muted US growth. API/ROW declined 8%/1% YoY respectively. Global specialty grew 15% YoY to USD266mn (down 2% QoQ). Gross margins expanded 200bps to 78.6% (down 120bps QoQ). EBITDA grew 11% YoY to Rs35bn with margins expanding 130bps YoY (+350bps QoQ) at 28.2% (our est. 26.5%). Adjusting fo...
Add Sun Pharma Ltd For Target Rs.1,900 By Centrum Broking Ltd
State Bank of India Ltd Buy State Bank of India Ltd @ 771-772 ; Target 779.00; Stop Loss 767.30 Sun Pharma Ltd Buy Sun Pharma Ltd @ 1542-1544 ; Target 1559.00; Stop Loss 1536.00 Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : State Bank of India Ltd And Sun Pharma Ltd By ICICI Direct
Load More